Bachelor of Law, LLB, Otago University
Independent Director – Chairman
Duncan has over 30 years of experience in business principally in the FMCG sector working across multiple international jurisdictions, most recently as Managing Director of Lion’s Asia Dairy business, leading Yum! International’s franchising business and as General Counsel and Company Secretary, leading corporate M&A activity, IPOs and privatisations.
He is currently Chief Executive Officer of China Road, a full service brand-building partner for Australian and New Zealand premium food producers looking to establish and grow their brands for long term success in the Chinese market.
He is Chairman of the Sydney Children’s Hospitals Foundation, a Director of Athletic Greens, Inc and has served as Chairman on a number of public and private boards, including Heineken-Lion Australia, Banksia Wines Ltd and Bevchain Australia Ltd.
He is co-owner of The Royal Hotel in Wyong on the Central Coast of New South Wales, Australia.
He chairs the Remuneration and Nominations Committee for GSH and he has been a Director since March 2019.
BE (Chem & Mats), MBA (Cranfield), CMInstD
Carl has significant hospitality experience. His senior management experience is primarily in the food & beverage sector with 14 years in DB Breweries, Lion Nathan and Heineken joint venture businesses in New Zealand, Asia and Australia including five years as Managing Director of the Heineken-Lion Joint Venture in Australia. His most recent senior management experience has been six years as CEO of pan-iwi owned Aotearoa Fisheries.
He is currently a Director of Hop Revolution Limited, Cawthron Institute and McCashin’s Brewery.
He has been a Director of GSH since July 2018.
Bachelor of Commerce (Accounting and Business Law)
Graduate Diploma in Finance and Applied Valuation (FINSIA)
Matt is an experienced finance professional with over 20 years’ experience in executive level positions (both public and private companies). He commenced his career as a Chartered Accountant in the field of restructuring and operational turnaround in an Australian mid-tier accounting firm where he was a Partner for ten years and then Senior Managing Director. In 2015 he founded the boutique corporate advisory firm Dynamic Corporate Investments of which he is Managing Director.
He brings extensive experience in growth strategies, operational efficiency consulting, business M&A (including acquisitions, sales and business unit carveouts) and capital structuring/ improvement. He has overseen major operational and financial restructurings of many listed companies including multi-national and cross border transactions. He has broad industry experience across the hospitality, retail, property, healthcare, mining and mining services, technology and childcare sectors. He has strong networks across the private equity, hedge fund and banking sectors.
He currently acts as director and company secretary for a number of ASX listed companies.
He chairs the Audit and Remuneration Committee for GSH and has been a Director since December 2019.
Bachelor of Commerce (Accounting and Finance) University of New South Wales
Member of Chartered Accountants Australia and New Zealand
Charles is an experienced corporate advisor, investor and business professional and a principal of Christie Whiting Vermunt Limited, a shareholder in the Company. His background is in investment banking where he was a Director of Lazard, a New York headquartered global investment bank, in Australia. At Lazard, he was involved in some of the largest restructurings, mergers and acquisitions and strategic advisory assignments in Australian history to a variety of public and private companies and governments.
Prior to Lazard, he was a Chartered Accountant at Deloitte. He recently returned to New Zealand from the United States where he was CEO of OTC pharmaceutical hydration brand Hydralyte™. He established the business in the United States and Canadian markets.
In addition to his work as an advisor, he has made a variety of direct investments into public and private companies across venture, biotech and resources.
He has been a Director since December 2019.